Erysipelas is a bacterial skin disease involving the deeper layers of the skin, caused by Group A streptococcal infection. The bacteria can enter the body through minor wounds in the skin or mucous membranes, and the disease develops when the body's immune resistance is low. Erysipelas has a rapid onset, and its typical symptoms include edematous erythema with clear boundaries, a tense and shiny surface, and rapid expansion to the surrounding areas. There may also be swollen lymph nodes and varying degrees of systemic symptoms, with the condition typically peaking within four to five days. The primary treatment for erysipelas involves anti-inflammatory medications, namely antibiotics. Penicillin is commonly used; if there is an allergy to penicillin, alternatives like erythromycin, azithromycin, roxithromycin, levofloxacin, or ciprofloxacin can be used. Early, adequate, and effective antibiotic treatment can alleviate systemic symptoms, control the spread of inflammation, and prevent recurrence.